Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib + Paclitaxel in Early HER2- Breast Cancer
NCT01484080Phase 2Completed
- Sponsor
- Spanish National Cancer Research Centre
- Start
- Oct 2011
- Primary completion
- Nov 2013
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nintedanib intravenous solution in breast cancer, sponsored by Spanish National Cancer Research Centre. Started Oct 2011; status: completed.
02
Drugs
nintedanib intravenous solution
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01484080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484080.